---
title: "Karyopharm Therapeutics Inc. Stock 12‑Month Price Target Raised to $15, Implies 69% Upside"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286456766.md"
description: "Karyopharm Therapeutics Inc.'s stock price target has been raised to $15, indicating a potential upside of 69%. This estimate comes from 7 analysts, with price forecasts ranging from $7 to $24 per share. The consensus rating remains a 'Buy' from 8 analysts, including 7 Buys and 1 Hold. This information is based on the closing price as of May 13."
datetime: "2026-05-14T19:20:07.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286456766.md)
  - [en](https://longbridge.com/en/news/286456766.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286456766.md)
---

# Karyopharm Therapeutics Inc. Stock 12‑Month Price Target Raised to $15, Implies 69% Upside

-   According to estimates from 7 analysts, Karyopharm Therapeutics Inc. stock's average price target has risen from $14.71 to $15, with forecasts ranging from $7 to $24 per share
-   Based on the May 13 closing price, the updated target implies approximately 69% potential upside
-   Consensus rating remains at “Buy” across 8 covering analysts, with 7 Buys, 1 Holds and 0 Sells

Explore more price target data and ratings for Karyopharm Therapeutics Inc. on the , and track all previous and future analyst recommendations for Karyopharm Therapeutics Inc. in the dedicated News Flow.

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [KPTI.US](https://longbridge.com/en/quote/KPTI.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Karyopharm (KPTI) Leans on SENTRY in Pivotal Call](https://longbridge.com/en/news/287005767.md)
- [RBC Capital Remains a Buy on Karyopharm Therapeutics (KPTI)](https://longbridge.com/en/news/286559865.md)
- [Luke Evnin Sells 22,184 Shares of Werewolf Therapeutics (NASDAQ:HOWL) Stock](https://longbridge.com/en/news/287219594.md)
- [The S&P 500 Just Completed Its 7th Straight Up Week. History Says It's Still Time to Buy.](https://longbridge.com/en/news/287006210.md)
- [Best Buy leak hints GTA VI pre-orders may start May 18](https://longbridge.com/en/news/286472709.md)